Eaton Vance Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-24,963
| Closed | -$860K | – | 1473 |
|
|
2020
Q3 | $860K | Hold |
24,963
| – | – | ﹤0.01% | 1027 |
|
|
2020
Q2 | $417K | Hold |
24,963
| – | – | ﹤0.01% | 1130 |
|
|
2020
Q1 | $360K | Hold |
24,963
| – | – | ﹤0.01% | 1115 |
|
|
2019
Q4 | $836K | Hold |
24,963
| – | – | ﹤0.01% | 1034 |
|
|
2019
Q3 | $523K | Hold |
24,963
| – | – | ﹤0.01% | 1103 |
|
|
2019
Q2 | $520K | Hold |
24,963
| – | – | ﹤0.01% | 1096 |
|
|
2019
Q1 | $558K | Hold |
24,963
| – | – | ﹤0.01% | 1040 |
|
|
2018
Q4 | $597K | Hold |
24,963
| – | – | ﹤0.01% | 966 |
|
|
2018
Q3 | $681K | Hold |
24,963
| – | – | ﹤0.01% | 975 |
|
|
2018
Q2 | $671K | Sell |
24,963
-24,963
| -50% | -$671K | ﹤0.01% | 960 |
|
|
2018
Q1 | $1.59M | Buy |
49,926
+24,963
| +100% | +$795K | ﹤0.01% | 897 |
|
|
2017
Q4 | $944K | Hold |
24,963
| – | – | ﹤0.01% | 856 |
|
|
2017
Q3 | $619K | Hold |
24,963
| – | – | ﹤0.01% | 913 |
|
|
2017
Q2 | $513K | Hold |
24,963
| – | – | ﹤0.01% | 934 |
|
|
2017
Q1 | $542K | Buy |
+24,963
| New | +$542K | ﹤0.01% | 888 |
|